USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Biopharmaceutical Excipients Market By Product (Carbohydrates, Solubilizers & Surfactants/Emulsifiers, Polyols, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Covid-19

Biopharmaceutical Excipients Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[195+ Pages Report] According to the report published by Facts and Factors, the global biopharmaceutical excipients market was valued at approximately USD 1.94 Billion in 2019, and is expected to generate revenue of around USD 3.07 Billion by end of 2026, growing at a CAGR of around 6.8% between 2020 and 2026.

logoGlobal Biopharmaceutical Excipients Market: Overview              

Excipients aid in the efficient linking of ingredients, adjust the absorption and stability of API and improve drug stabilization in the dosage form, all of which are essential in biopharmaceuticals. As a consequence, choosing the right excipient is crucial for lowering production costs and enhancing the patient experience. The implementation of biopharmaceutical excipients is a nascent technology that has made strides in the field of drug delivery technologies. As a result, it is reasonable to forecast that the global biopharmaceutical excipients market will develop at a healthy pace in the coming years.

logoGlobal Biopharmaceutical Excipients Market: Growth Factors

With advances in the field of the pharmaceutical industry, the global biopharmaceutical excipients market is expected to develop. Biopharmaceutical excipients aren't active drugs, but they're important in the development of a variety of drugs. The function of biopharmaceutical excipients during the healing phase improves the tasks of the active drugs, and this aspect has contributed to their popularity. Within the pharmaceutical industry, the use of biopharmaceutical excipients is a strategic operation, and this is also a key factor in terms of market development.

The global biopharmaceutical excipients market's investment portfolio is projected to increase in the coming years. This is largely due to the existence of streamlined pharmaceutical production and the medical discharge industry. Medical practitioners and physicians have recognized the role of biopharmaceutical excipients in the healing process. In recent years, this aspect has been a significant driver of demand in the global biopharmaceutical excipients industry. A development that has aided market growth is the existence of multiple distribution networks for pharmaceutical products.

logoGlobal Biopharmaceutical Excipients Market: Segmentation

In 2020, carbohydrate-based excipient products led the market, and this trend is projected to continue during the forecast period. The dominance of the segment can be traced to the widespread use of fructose, dextrose, and sucrose in different drug formulations. In addition, the growing use of carbohydrate as bulking agents in the lyophilisation of biomolecules like proteins is fuelling segment development. Because of its extensive use in drug production, the starch segment is projected to rise at the highest rate. It can be used as a binder, diluent, and disintegrate in a variety of non-prescription drugs, biopharmaceuticals, and dietary supplements. Because of its cost-effectiveness, inert nature, and high availability, starch is becoming more commonly used.

Because of the simple availability of goods at fair prices, sucrose is used as a framing and balancing out provider in about 80% of lyophilized monoclonal counter-acting agent-dependent concepts. Furthermore, due to its well-defined safety profile, starch is commonly used in a variety of medication products. It's possible to modify it to improve its properties, which helps with the design of complex distributed systems for large molecules.

logoGlobal Biopharmaceutical Excipients Market: Regional Analysis

North America had the largest market share in 2020, thanks to a number of factors including the involvement of major players, increased opioid production, and a massive population base. Collaborations are taking place in this area to establish biopharmaceutical excipients. Due to the existence of large CMOs involved in drug production, the demand in Asia Pacific is projected to expand at the fastest pace. China, India, and South Korea, for example, are heavily involved in the production of bio-similar in this area. Affordability, a favourable regulatory environment, cost advantages, and the existence of a vast population base are all factors for the widespread production of bio-similar. As a result, bio-similar manufacturing necessitates the use of biopharmaceutical excipients to ensure drug stability.

logoGlobal Biopharmaceutical Excipients Market: Competitive Players

Key participants in Biopharmaceutical Excipients market are Evonik Industries AG, Associated British Foods plc, Signet Excipients Pvt. Ltd (IMCD), BASF SE, Clariant, Spectrum Chemical Manufacturing Corp., Merck KGaA, Roquette Frères, Sigachi Industries Limited, and others.

logoBiopharmaceutical Excipients Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa

Rest of MEA

key report pointers

Covid-19

Biopharmaceutical Excipients Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Biopharmaceutical Excipients
    2. 1.2. Global Biopharmaceutical Excipients Market, 2019 & 2026 (USD Million)
    3. 1.3. Global Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
    4. 1.4. Global Biopharmaceutical Excipients Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    5. 1.5. Global Biopharmaceutical Excipients Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
  2. Chapter 2 Biopharmaceutical Excipients Market – Type Analysis
    1. 2.1. Global Biopharmaceutical Excipients Market – Type Overview
    2. 2.2. Global Biopharmaceutical Excipients Market Share, by Type, 2019 & 2026 (USD Million)
    3. 2.3. Carbohydrates
      1. 2.3.1. Global Carbohydrates Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
    4. 2.4. Solubilizers & Surfactants/Emulsifiers
      1. 2.4.1. Global Solubilizers & Surfactants/Emulsifiers Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
    5. 2.5. Polyols
      1. 2.5.1. Global Polyols Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
    6. 2.6. Others
      1. 2.6.1. Global Others Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
  3. Chapter 3 Biopharmaceutical Excipients Market – Regional Analysis
    1. 3.1. Global Biopharmaceutical Excipients Market Regional Overview
    2. 3.2. Global Biopharmaceutical Excipients Market Share, by Region, 2019 & 2026 (USD Million)
    3. 3.3. North America
      1. 3.3.1. North America Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
        1. 3.3.1.1. North America Biopharmaceutical Excipients Market, by Country, 2016 - 2026 (USD Million)
      2. 3.3.2. North America Biopharmaceutical Excipients Market, by Type, 2016 – 2026
        1. 3.3.2.1. North America Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      3. 3.3.3. U.S.
        1. 3.3.3.1. U.S. Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      4. 3.3.4. Canada
        1. 3.3.4.1. Canada Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
    4. 3.4. Europe
      1. 3.4.1. Europe Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
        1. 3.4.1.1. Europe Biopharmaceutical Excipients Market, by Country, 2016 - 2026 (USD Million)
      2. 3.4.2. Europe Biopharmaceutical Excipients Market, by Type, 2016 – 2026
        1. 3.4.2.1. Europe Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      3. 3.4.3. Germany
        1. 3.4.3.1. Germany Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      4. 3.4.4. France
        1. 3.4.4.1. France Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      5. 3.4.5. U.K.
        1. 3.4.5.1. U.K. Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      6. 3.4.6. Italy
        1. 3.4.6.1. Italy Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      7. 3.4.7. Spain
        1. 3.4.7.1. Spain Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      8. 3.4.8. Rest of Europe
        1. 3.4.8.1. Rest of Europe Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
    5. 3.5. Asia Pacific
      1. 3.5.1. Asia Pacific Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
        1. 3.5.1.1. Asia Pacific Biopharmaceutical Excipients Market, by Country, 2016 - 2026 (USD Million)
      2. 3.5.2. Asia Pacific Biopharmaceutical Excipients Market, by Type, 2016 – 2026
        1. 3.5.2.1. Asia Pacific Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      3. 3.5.3. China
        1. 3.5.3.1. China Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      4. 3.5.4. Japan
        1. 3.5.4.1. Japan Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      5. 3.5.5. India
        1. 3.5.5.1. India Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      6. 3.5.6. South Korea
        1. 3.5.6.1. South Korea Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      7. 3.5.7. South-East Asia
        1. 3.5.7.1. South-East Asia Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      8. 3.5.8. Rest of Asia Pacific
        1. 3.5.8.1. Rest of Asia Pacific Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
    6. 3.6. Latin America
      1. 3.6.1. Latin America Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
        1. 3.6.1.1. Latin America Biopharmaceutical Excipients Market, by Country, 2016 - 2026 (USD Million)
      2. 3.6.2. Latin America Biopharmaceutical Excipients Market, by Type, 2016 – 2026
        1. 3.6.2.1. Latin America Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      3. 3.6.3. Brazil
        1. 3.6.3.1. Brazil Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      4. 3.6.4. Mexico
        1. 3.6.4.1. Mexico Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      5. 3.6.5. Rest of Latin America
        1. 3.6.5.1. Rest of Latin America Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
    7. 3.7. The Middle-East and Africa
      1. 3.7.1. The Middle-East and Africa Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
        1. 3.7.1.1. The Middle-East and Africa Biopharmaceutical Excipients Market, by Country, 2016 - 2026 (USD Million)
      2. 3.7.2. The Middle-East and Africa Biopharmaceutical Excipients Market, by Type, 2016 – 2026
        1. 3.7.2.1. The Middle-East and Africa Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      3. 3.7.3. GCC Countries
        1. 3.7.3.1. GCC Countries Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      4. 3.7.4. South Africa
        1. 3.7.4.1. South Africa Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      5. 3.7.5. Rest of Middle-East Africa
        1. 3.7.5.1. Rest of Middle-East Africa Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
  4. Chapter 4 Biopharmaceutical Excipients Market – Competitive Landscape
    1. 4.1. Competitor Market Share – Revenue
    2. 4.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 4.3. Strategic Developments
      1. 4.3.1. Acquisitions and Mergers
      2. 4.3.2. New Products
      3. 4.3.3. Research & Development Activities
  5. Chapter 5 Company Profiles
    1. 5.1. BASF SE
      1. 5.1.1. Company Overview
      2. 5.1.2. Product/Service Portfolio
      3. 5.1.3. BASF SE Sales, Revenue, and Gross Margin
      4. 5.1.4. BASF SE Revenue and Growth Rate
      5. 5.1.5. BASF SE Market Share
      6. 5.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 5.2. Evonik Industries AG
      1. 5.2.1. Company Overview
      2. 5.2.2. Product/Service Portfolio
      3. 5.2.3. Evonik Industries AG Sales, Revenue, and Gross Margin
      4. 5.2.4. Evonik Industries AG Revenue and Growth Rate
      5. 5.2.5. Evonik Industries AG Market Share
      6. 5.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 5.3. Associated British Foods plc
      1. 5.3.1. Company Overview
      2. 5.3.2. Product/Service Portfolio
      3. 5.3.3. Associated British Foods plc Sales, Revenue, and Gross Margin
      4. 5.3.4. Associated British Foods plc Revenue and Growth Rate
      5. 5.3.5. Associated British Foods plc Market Share
      6. 5.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 5.4. Merck KGaA
      1. 5.4.1. Company Overview
      2. 5.4.2. Product/Service Portfolio
      3. 5.4.3. Merck KGaA Sales, Revenue, and Gross Margin
      4. 5.4.4. Merck KGaA Revenue and Growth Rate
      5. 5.4.5. Merck KGaA Market Share
      6. 5.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 5.5. Signet Excipients Pvt. Ltd (IMCD)
      1. 5.5.1. Company Overview
      2. 5.5.2. Product/Service Portfolio
      3. 5.5.3. Signet Excipients Pvt. Ltd (IMCD) Sales, Revenue, and Gross Margin
      4. 5.5.4. Signet Excipients Pvt. Ltd (IMCD) Revenue and Growth Rate
      5. 5.5.5. Signet Excipients Pvt. Ltd (IMCD) Market Share
      6. 5.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 5.6. IMCD
      1. 5.6.1. Company Overview
      2. 5.6.2. Product/Service Portfolio
      3. 5.6.3. IMCD Sales, Revenue, and Gross Margin
      4. 5.6.4. IMCD Revenue and Growth Rate
      5. 5.6.5. IMCD Market Share
      6. 5.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 5.7. Sigachi Industries Limited
      1. 5.7.1. Company Overview
      2. 5.7.2. Product/Service Portfolio
      3. 5.7.3. Sigachi Industries Limited Sales, Revenue, and Gross Margin
      4. 5.7.4. Sigachi Industries Limited Revenue and Growth Rate
      5. 5.7.5. Sigachi Industries Limited Market Share
      6. 5.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 5.8. Clariant
      1. 5.8.1. Company Overview
      2. 5.8.2. Product/Service Portfolio
      3. 5.8.3. Clariant Sales, Revenue, and Gross Margin
      4. 5.8.4. Clariant Revenue and Growth Rate
      5. 5.8.5. Clariant Market Share
      6. 5.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 5.9. Spectrum Chemical Manufacturing Corp.
      1. 5.9.1. Company Overview
      2. 5.9.2. Product/Service Portfolio
      3. 5.9.3. Spectrum Chemical Manufacturing Corp. Sales, Revenue, and Gross Margin
      4. 5.9.4. Spectrum Chemical Manufacturing Corp. Revenue and Growth Rate
      5. 5.9.5. Spectrum Chemical Manufacturing Corp. Market Share
      6. 5.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 5.10. Roquette Frères
      1. 5.10.1. Company Overview
      2. 5.10.2. Product/Service Portfolio
      3. 5.10.3. Roquette Frères Sales, Revenue, and Gross Margin
      4. 5.10.4. Roquette Frères Revenue and Growth Rate
      5. 5.10.5. Roquette Frères Market Share
      6. 5.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  6. Chapter 6 Biopharmaceutical Excipients — Industry Analysis
    1. 6.1. Introduction and Taxonomy
    2. 6.2. Biopharmaceutical Excipients Market – Key Trends
      1. 6.2.1. Market Drivers
      2. 6.2.2. Market Restraints
      3. 6.2.3. Market Opportunities
    3. 6.3. Value Chain Analysis
    4. 6.4. Key Mandates and Regulations
    5. 6.5. Technology Roadmap and Timeline
    6. 6.6. Biopharmaceutical Excipients Market – Attractiveness Analysis
      1. 6.6.1. By Type
      2. 6.6.2. By Region
  7. Chapter 7 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 7.1. Biopharmaceutical Excipients Industrial Chain Analysis
    2. 7.2. Downstream Buyers
    3. 7.3. Distributors/Traders List
  8. Chapter 8 Marketing Strategy Analysis
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trends
    5. 8.5. Economic/Political Environmental Change
  9. Chapter 9 Report Conclusion & Key Insights
    1. 9.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 9.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  10. Chapter 10 Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Statistical Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
      4. 10.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of Biopharmaceutical Excipients
      Fig.2	Global Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.3	Global Biopharmaceutical Excipients Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.4	Global Biopharmaceutical Excipients Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.5	Global Biopharmaceutical Excipients Market Share, by Type, 2019 & 2026 (USD Million)
      Fig.6	Global Carbohydrates Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.7	Global Solubilizers & Surfactants/Emulsifiers Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.8	Global Polyols Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.9	Global Others Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.10	Global Biopharmaceutical Excipients Market Share, by Region, 2019 & 2026 (USD Million)
      Fig.11	North America Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.12	U.S. Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.13	Canada Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.14	Europe Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.15	Germany Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.16	France Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.17	U.K. Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.18	Italy Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.19	Spain Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.20	Rest of Europe Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.21	Asia Pacific Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.22	China Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.23	Japan Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.24	India Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.25	South  Korea Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.26	South-East Asia Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.27	Rest of Asia Pacific Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.28	Latin America Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.29	Brazil Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.30	Mexico Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.31	Rest of Latin America Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.32	The Middle-East and Africa Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.33	GCC Countries Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.34	South Africa Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.35	Rest of Middle-East Africa Biopharmaceutical Excipients Market, 2016 – 2026 (USD Million)
      Fig.36	Competitor Market Share – Revenue
      Fig.37	BASF SE Revenue and Growth Rate
      Fig.38	BASF SE Market Share
      Fig.39	Evonik Industries AG Revenue and Growth Rate
      Fig.40	Evonik Industries AG Market Share
      Fig.41	Associated British Foods plc Revenue and Growth Rate
      Fig.42	Associated British Foods plc Market Share
      Fig.43	Merck KGaA Revenue and Growth Rate
      Fig.44	Merck KGaA Market Share
      Fig.45	Signet Excipients Pvt. Ltd (IMCD) Revenue and Growth Rate
      Fig.46	Signet Excipients Pvt. Ltd (IMCD) Market Share
      Fig.47	IMCD Revenue and Growth Rate
      Fig.48	IMCD Market Share
      Fig.49	Sigachi Industries Limited Revenue and Growth Rate
      Fig.50	Sigachi Industries Limited Market Share
      Fig.51	Clariant Revenue and Growth Rate
      Fig.52	Clariant Market Share
      Fig.53	Spectrum Chemical Manufacturing Corp. Revenue and Growth Rate
      Fig.54	Spectrum Chemical Manufacturing Corp. Market Share
      Fig.55	Roquette Frères Revenue and Growth Rate
      Fig.56	Roquette Frères Market Share
      Fig.57	Market Dynamics
      Fig.58	Global Biopharmaceutical Excipients – Value Chain Analysis
      Fig.59	Key Mandates and Regulations
      Fig.60	Technology Roadmap and Timeline
      Fig.61	Market Attractiveness Analysis – By Type
      Fig.62	Market Attractiveness Analysis – By Region
      Fig.63	Biopharmaceutical Excipients Industrial Chain Analysis
      Fig.64	Market Channels
      Fig.65	Marketing Channel Development Trend
      Fig.66	Growth in World Gross Product, 2008-2018
      

      List of Tables

      Table 1	Global Biopharmaceutical Excipients Market, 2019 & 2026 (USD Million)
      Table 2	Global Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      Table 3	Global Biopharmaceutical Excipients Market, by Region, 2016 – 2026 (USD Million)
      Table 4	North America Biopharmaceutical Excipients Market, by Country, 2016 – 2026 (USD Million)
      Table 5	North America Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      Table 6	Europe Biopharmaceutical Excipients Market, by Country, 2016 – 2026 (USD Million)
      Table 7	Europe Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      Table 8	Asia Pacific Biopharmaceutical Excipients Market, by Country, 2016 – 2026 (USD Million)
      Table 9	Asia Pacific Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      Table 10 Latin America Biopharmaceutical Excipients Market, by Country, 2016 – 2026 (USD Million)
      Table 11 Latin America Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      Table 12 The Middle-East and Africa Biopharmaceutical Excipients Market, by Country, 2016 – 2026 (USD Million)
      Table 13 The Middle-East and Africa Biopharmaceutical Excipients Market, by Type, 2016 – 2026 (USD Million)
      Table 14 Global Biopharmaceutical Excipients Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
      Table 15 Global Biopharmaceutical Excipients Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 16 Acquisitions and Mergers
      Table 17 Market Drivers – Impact Analysis
      Table 18 Market Restraints
      Table 19 Market Opportunities
      Table 20 Major Buyers of Biopharmaceutical Excipients
      Table 21 Distributors/Traders of Biopharmaceutical Excipients by Region
      

Covid-19

Biopharmaceutical Excipients Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Evonik Industries AG
  • Associated British Foods plc
  • Signet Excipients Pvt. Ltd (IMCD)
  • BASF SE
  • Clariant
  • Spectrum Chemical Manufacturing Corp.
  • Merck KGaA
  • Roquette Frères
  • Sigachi Industries Limited

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Biopharmaceutical Excipients Market.
According to Facts and Factors research report, the global Biopharmaceutical Excipients Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Biopharmaceutical Excipients Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Biopharmaceutical Excipients Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Biopharmaceutical Excipients Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Pharmacovigilance and Drug Safety Software Market

[187+ Pages Report] According to the latest report titled Global Pharmacovigilance and Drug Safety Software Market published by Facts Factors, the study offers a detailed and comprehensive read. The global pharmacovigilance and drug safety software market witnessed a significant market value of U...

Published Date : 02-Nov-2021 | | Category : | Pages : 187 | Format : Read more

Inquiry for Buying Request Sample
report img

Biohacking Market

[197+ Pages Report] The latest report published by Facts Factors titled global biohacking markethas a global perspective on the latter coupled with the market size, volume, drivers, and restraints to name a few. We estimate that the biohacking market will hold a value of USD 14.65 Billion in the ...

Published Date : 06-Aug-2021 | | Category : | Pages : 197 | Format : Read more

Inquiry for Buying Request Sample